T
Last Price
52 Week Range
NOK1.80 - NOK5.49
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | NOK1.54B |
EV | NOK1.32B |
Shares Outstanding | 354.14M |
Beta | -0.22 |
Industry | Biotechnology |
Analyst Rating | SELL |
Analyst Target Price | |
Number of Analysts | 1 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
T
Thor Medical ASA
TRMED
Sector
Healthcare
Industry
Biotechnology
CEO
Kurth, Jasper
Employees
13
Website
www.thormedical.noIPO Date
2015-03-23
Headquarters
Drammensveien 167, Oslo, Oslo, 0277, Norway
The last closing price of Thor Medical (TRMED) is NOK4.89, reflecting a +6.54% change from the prior session. Last updated: April 1, 2026 at 8:20 AM Eastern Time
Review of Recent TRMED Stock Performance trends:Past 1 Month: Thor Medical (TRMED) shares changed by -10.71%.Past 3 Months: The stock recorded a change of +0.71%.Past 6 Months: TRMED shares posted a change of +18.06%. Last updated: March 7, 2026 at 8:43 PM Eastern Time
Over the last year, Thor Medical (TRMED) has established a 52-week price range between a high of NOK5.49 and a low of NOK1.80. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 8:43 PM Eastern Time
Thor Medical (TRMED) is considered a low volatility stock. It has a beta of -0.22, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 0.22 times the market's movement. Over the past 52 weeks, TRMED has traded within a NOK1.80 – NOK5.49 range. Last updated: March 7, 2026 at 8:43 PM Eastern Time
Based on current TRMED analyst forecasts, the consensus price target for Thor Medical (TRMED) is NOK3.50 for 2027. Relative to the current price of NOK4.89, this implies a potential downside of -17.65%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: April 1, 2026 at 8:20 AM Eastern Time
A NOK1,000 investment in Thor Medical 5 years ago, when the stock was trading around NOK25.91, would be worth approximately NOK188.70 today, based solely on share price performance (excluding dividends). This represents a total return of -81.13% over the period, equivalent to a compound annual growth rate (CAGR) of -28.36%. Past performance reflects historical price movements only and does not imply future results. Last updated: March 7, 2026 at 8:43 PM Eastern Time
The current Thor Medical (TRMED) market capitalization is approximately NOK1.54B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Thor Medical's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 8:43 PM Eastern Time
Thor Medical (TRMED) does not currently pay a dividend. Over the last twelve months (LTM), the company paid NOK0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Analyst assessments of whether Thor Medical (TRMED) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: NOK4.89Consensus price target: NOK3.50Implied return: -17.65% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: April 1, 2026 at 8:20 AM Eastern Time
Based on the latest available analyst coverage, Thor Medical (TRMED) currently carries a Sell consensus rating. Analysts' average TRMED price target is NOK3.50. Relative to the current share price of NOK4.89, this suggests a potential price change of approximately -17.65%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 1, 2026 at 8:20 AM Eastern Time
Like other publicly traded stocks, Thor Medical (TRMED) shares are bought and sold on stock exchanges such as OB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Thor Medical (TRMED) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add TRMED to your watchlist.
Thor Medical trades under the ticker symbol TRMED on the OB stock exchange. The ticker TRMED is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Thor Medical (TRMED) employs approximately 13 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 8:43 PM Eastern Time
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers